Products

Altris AI
Altris AI
Ophthalmology AI
Altris AI is an FDA-cleared, AI-powered cloud platform for automated OCT scan analysis, detecting over 70 retinal pathologies and 40+ biomarkers. It supports ophthalmologists, optometrists, and pharma with vendor-neutral data management, quantitative progression tracking, and research-ready data export.

See all 1 product →

About Altris AI

Altris AI offers an advanced, AI-powered ophthalmic image management system designed to significantly enhance the diagnostic workflow for eye care professionals. The platform specializes in automated analysis of Optical Coherence Tomography (OCT) scans, capable of detecting and quantifying over 70 distinct retina pathologies and biomarkers. This includes prevalent conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), and various forms of glaucoma, as well as less common retinal diseases like central retinal vein and artery occlusions, vitelliform dystrophy, and macular telangiectasia.

The system provides real-time diagnostic support by differentiating between pathological and non-pathological b-scans, performing quantitative analysis with precise area and volume measurements, and offering early glaucoma risk assessment through advanced optic disc and ganglion cell complex (GCC) analysis. Altris AI is vendor-neutral, compatible with OCT devices from multiple manufacturers, and facilitates consistent image interpretation and tracking of disease progression over time. This robust AI decision support aims to improve diagnostic accuracy, streamline clinical efficiency, and ultimately contribute to better patient outcomes by enabling earlier detection and more informed treatment decisions. The platform is FDA-cleared (510K), CE-certified, and adheres to HIPAA and GDPR compliance standards, ensuring data security and regulatory adherence.

Focus Areas

Ophthalmology AI OCT scan analysis retinal disease detection glaucoma detection age-related macular degeneration (AMD) detection diabetic retinopathy (DR) detection medical image management decision support systems computer vision deep learning

Business Intelligence

TechnologyCloud-based SaaS platform, AI-powered medical image management system (Altris IMS), computer vision, deep learning algorithms, Altris Sync app for direct OCT device integration, vendor-neutral OCT compatibility

What Physicians Need to Know

Ophthalmology AI & OCT Analysis
Altris AI specializes in AI-powered analysis of Optical Coherence Tomography (OCT) scans, capable of differentiating between pathological and non-pathological b-scans. The platform detects over 70 retina pathologies and biomarkers, including rare and early-stage conditions.
Retinal Disease Detection
The system offers comprehensive detection for major retinal diseases such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and their associated biomarkers like geographic atrophy (GA), diabetic macular edema (DME), and various fluid types (Intraretinal Cystoid Fluid, Subretinal Fluid).
Glaucoma Detection & Risk Assessment
Altris AI provides early glaucoma detection through advanced optic disc analysis, evaluating parameters like optic nerve size, cup size, and rim area. It also focuses on analyzing the OCT ganglion cell layer thickness and asymmetry to determine glaucoma risk.
Medical Image Management & Decision Support
The platform functions as an ophthalmic image management system (IMS) and a clinical decision support system (CDSS). It streamlines the OCT workflow by automating screening, segmentation, classification, and report generation, providing real-time insights and alerts.
Key Differentiators
Altris AI stands out with its ability to detect a significantly wider range of pathologies (70+ to 100+) compared to many competitors, its vendor-neutral compatibility with 8-9 major OCT manufacturers, and its high cumulative AI accuracy (e.g., 91%). It's a cloud-based, CE-certified platform, with FDA 510(k) clearance as an IMS system (AI/ML models for research purposes only in USA).
Technology Stack
The core technology leverages computer vision and deep learning algorithms, trained on millions of graphically labeled OCT scans by retina experts. The web-based platform utilizes technologies like React, Laravel, and AWS for its infrastructure.
Quantitative Analysis & Progression Tracking
The system offers quantitative measurements of over 40 retinal biomarkers (e.g., fluid volume, retinal layer thickness, drusen volume) and provides progression tracking with intuitive visualizations (graphs, percentages) to monitor disease activity and treatment response over time.
Physician Tip

For physicians, Altris AI acts as an intelligent co-pilot, enhancing diagnostic confidence and accuracy by providing a 'second opinion' and detecting subtle, early, or rare pathologies that might otherwise be missed. It significantly boosts efficiency by automating OCT scan analysis, reducing manual review time, and streamlining the workflow, allowing more time for direct patient interaction and personalized care. The platform's ability to provide clear, color-coded visuals and comprehensive reports also aids in patient education, fostering better understanding and trust. Furthermore, its vendor-neutrality ensures seamless integration with existing OCT devices, making it a versatile tool for various clinical settings.

Altris AI is a vendor-neutral platform, compatible with OCT devices from 8-9 major manufacturers. It offers an application, Altris Sync, to automatically transfer OCT scans directly from devices, eliminating manual upload steps. The system is designed to integrate seamlessly with existing clinical infrastructure, including EMR/EHR systems.

Products by Altris AI

1 product in the directory

Altris AI
Altris AI
Ophthalmology AI
Altris AI is an FDA-cleared, AI-powered cloud platform for automated OCT scan analysis, detecting over 70 retinal pathologies and 40+ biomarkers. It supports ophthalmologists, optometrists, and pharma with vendor-neutral data management, quantitative progression tracking, and research-ready data export.

What the Web Says

Altris AI is an AI-powered ophthalmic image management system designed to assist ophthalmologists and optometrists in interpreting OCT scans and making diagnostic decisions. It helps differentiate pathological from non-pathological scans, define over 100 pathologies and pathological signs, and can accelerate OCT examinations. The software is praised for its innovative approach and ability to provide confidence to less experienced specialists.

Overall: Positive

Strengths

  • Helps differentiate pathological scans from non-pathological OCT scans quickly.
  • Defines over 100 pathologies and pathological signs, including rare and early-stage ones.
  • Increases confidence for less experienced ophthalmologists and optometrists in OCT interpretation.
  • Accelerates OCT examinations, allowing clinics to serve more patients.
  • Seamless integration and outstanding customer support.
  • FDA clearance, CE certification, and GDPR/HIPAA compliant.

Limitations

  • Limited number of reviews on platforms like G2 and Capterra, making it difficult to provide comprehensive buying insight.
  • One Reddit comment suggests that AI in general, while improving, still has a high margin of error in detecting normal anatomical differences versus concerning lesions.
  • Some general AI training platforms mentioned on Reddit have issues with instability, low pay, or poor support, though these are not specific to Altris AI.

Based on reviews from: G2, Altris AI Reviews (from Altris AI website), Capterra, Software Advice, GetApp Australia, Slashdot, Reddit

Last updated: 2026-08-13

Videos

News, demos, and interviews about Altris AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Altris AI →

View all on YouTube

Press & Coverage

Ophthalmology Times
Altris unveils artificial intelligence platform for automated OCT scans analysis
Altris AI launched an artificial intelligence platform for automated OCT scan analysis, capable of differentiating between pathological and non-pathological b-scans and defining over 100 retina pathologies. The cloud-based platform aims to set higher diagnostic standards and address preventable blindness globally.
2022-11
Ophthalmology Times
AI-diagnostics startup Altris AI raises $1 million to prevent blindness
Altris AI, a US-based startup originally from Ukraine, raised $1 million in funding led by Runa Capital to scale its AI-enabled eye care diagnostics solution. The platform detects over 100 pathologies and is installed in more than 30 clinics.
2022-12
Healio
FDA grants 510(k) clearance to Altris IMS platform for OCT scans
Altris AI's IMS platform, designed to store, organize, and support improved analysis of OCT scans, received FDA 510(k) clearance. This clearance signifies the platform's safety and effectiveness, moving it closer to commercialization in the U.S. market.
2023-09
VisionMonday.com
Altris, Inc. Announces FDA Clearance of AI-powered Image Management System for OCT Analysis
Altris, Inc. announced FDA 510(k) clearance for its IMS platform, an AI-powered image and data management system for OCT analysis. The platform offers features like manual annotations, comparison, progression tracking, and smart reporting to enhance OCT examination analysis.
2023-10
Healio
Q&A: Altris AI launches AI-powered optic disc analysis
Altris AI expanded its capabilities to include glaucoma detection with the launch of its AI-powered optic disc analysis module. This new module aims to improve early detection of glaucoma and prevent irreversible vision loss.
2025-03
Review of Optometry
AI-Driven Eye Care Technology Now Works With 8 Different OCTs
Altris AI released Altris Sync, a secure application that directly synchronizes AI with optical coherence tomography (OCT) devices from eight manufacturers. This streamlines OCT analysis and provides deeper data insights for earlier detection and more effective treatment planning.
2025-07
aiineyecare.com
Altris AI's Latest Tech Flags Pathologies, Biomarkers in OCT Scans
Altris AI introduced an update to its technology that automatically flags OCT scans for over 70 popular biomarkers and pathologies of disease. This functionality allows eye care professionals to instantly identify specific retina conditions for clinical or research purposes.
2025-09
Optical Journal News
Altris AI announces Early Glaucoma Risk Analysis Module launch at 100% Optical
Altris AI announced the launch of its new Early Glaucoma Risk Analysis Module at 100% Optical. The platform, which is FDA-cleared and CE-certified, can detect over 70 retina pathologies and biomarkers.
2026-02

Frequently Asked Questions

Altris AI is an AI-powered platform designed to enhance ophthalmic diagnostics by analyzing OCT scans. It utilizes deep learning and computer vision algorithms to identify, localize, and quantify over 70 retinal pathologies and biomarkers, aiming to improve early detection and treatment decisions for physicians.
Altris AI provides automated analysis of OCT scans to detect and monitor key biomarkers for Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma. Its algorithms can identify subtle changes, quantify fluid volumes, and analyze optic disc parameters and ganglion cell complex (GCC) asymmetry, providing quantitative data to support physicians in diagnosing and managing these prevalent retinal diseases.
Altris AI's core technology relies on advanced deep learning and computer vision algorithms trained on millions of graphically labeled OCT scans. This enables the platform to perform highly accurate segmentation, classification, and quantification of retinal structures and pathologies, acting as a powerful decision support system.
Altris AI is committed to regulatory compliance, holding the CE Mark for medical devices in Europe and having received FDA 510(k) clearance as an image management system for OCT. The platform also adheres to strict data privacy regulations such as GDPR and HIPAA to ensure patient data security.
Altris AI is designed for seamless integration with existing medical image management systems, including PACS and EMRs, through standard protocols like DICOM. It functions as a vendor-neutral decision support system, providing ophthalmologists with AI-generated insights directly within their established clinical workflows to aid in diagnosis and treatment planning.
Altris AI typically offers flexible subscription-based pricing models, with a starting price around $149-$249 per month, and also provides free trials. The company provides comprehensive technical support, including onboarding, training for clinical staff, and ongoing maintenance to ensure optimal system performance.
Altris AI has established partnerships with leading ophthalmic device manufacturers like Topcon Healthcare, Optopol, and Huvitz, and collaborates with academic institutions and pharmaceutical companies such as Roche and Astellas. The company, founded in 2017, demonstrates stability through ongoing investment in R&D and a clear vision to prevent blindness by advancing AI in ophthalmology, serving over 500 eye care businesses worldwide.

Investors

Who's funded Altris AI.

Related Companies

RetiVue is a healthcare AI company specializing in novel widefield retinal camera technology and eye care cloud services. Their mission is to prevent blindness in underserved and medically at-risk populations by providing affordable, high-definition retinal imaging solutions. The company’s flagship product, the EntireEye Imaging System, offers non-contact, non-mydriatic, high-definition image capture with up to a […]

AI Optics is a healthcare AI company dedicated to transforming point-of-care diagnostics through innovative AI-powered retinal screening technology. The company develops portable hardware and AI-based software to bring eye screening out of specialist offices and into primary care and retail health settings, aiming to increase access to eye screening and empower healthcare professionals to make […]

Thirona is a Dutch MedTech company specializing in artificial intelligence (AI) for advanced medical image analysis, primarily focusing on thoracic CT scans, chest X-rays, and retinal images. Founded by scientists Eva van Rikxoort and Bram van Ginneken from the Radboud University Medical Center, Thirona aims to bridge the gap between academic advancements in medical image […]

Google Health, an initiative (formerly a division) of Google, aims to leverage Google’s technology, particularly AI, to improve health outcomes globally. The company focuses on developing AI-powered tools and products to enhance the efficiency of healthcare workflows, reduce administrative burdens, accelerate innovation, and decrease costs. For physicians, this translates to tools like Google Care Studio, […]

Optivate is a healthcare AI company that provides a unified ophthalmology EHR platform designed to streamline workflows, reduce administrative burden, and improve patient care. The platform is purpose-built for ophthalmology and eye care practices, rather than being adapted from generic or multi-specialty systems. It integrates clinical care, practice management, revenue cycle, patient engagement, and optical […]

Orbis International is a global non-profit organization dedicated to preventing blindness and treating blinding eye diseases in low- and middle-income countries. They achieve this through a multi-faceted approach that includes hands-on training, public health education, advocacy, and local partnerships. A cornerstone of their work is the Flying Eye Hospital, a fully accredited ophthalmic teaching hospital […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.